Biotricity (BTCY) Projected to Announce Quarterly Earnings on Tuesday

Biotricity (NASDAQ:BTCY) is expected to post its Q4 2026 resultson Tuesday, July 21st. Analysts expect Biotricity to announce earnings of ($0.08) per share and revenue of $4.10 million for the quarter. Individuals can check the company’s upcoming Q4 2026 earning report page for the latest details on the call scheduled for Friday, July 24, 2026 at 4:00 PM ET.

Biotricity Price Performance

Shares of Biotricity stock opened at $0.12 on Tuesday. Biotricity has a 1 year low of $0.09 and a 1 year high of $0.75. The firm has a market cap of $3.47 million, a PE ratio of -0.11 and a beta of 1.14. The company has a 50 day simple moving average of $0.15 and a two-hundred day simple moving average of $0.22.

Biotricity Company Profile

Biotricity, Inc (NASDAQ:BTCY) is a digital health company specializing in remote patient monitoring solutions across cardiovascular and chronic disease management. The firm develops and commercializes a patented wearable biosensor platform designed to capture continuous physiological data, including electrocardiogram (ECG) readings and heart rate variability. This integrated system combines lightweight, adhesive biosensors with cloud-based analytics and clinician-facing software to support early detection of cardiac arrhythmias and facilitate telehealth care delivery.

The company’s flagship offering, the Bioflux™ platform, comprises a small, single-use wearable device that transmits real-time data to a secure portal, where advanced algorithms analyze cardiac patterns and generate clinician alerts.